NextPlat Corp Reports Q2 2026 Financial Results with Revenue Decline but Improved Gross Profit

NextPlat Corp reported its financial results for the second quarter and first half of 2026, revealing a decline in revenue but improvements in gross profit and operating loss. For the three months ended June 30, 2026, the company generated net revenues of $11.9 million, a decrease of 10% from $13.2 million in the same period of 2025. The decline was primarily attributed to a drop in revenue from the Healthcare Operations segment, which fell from $9.1 million to $7.8 million. However, gross profit increased significantly to $4.7 million, up 63% from $2.9 million year-over-year, resulting in a gross margin improvement from 22% to 40%.

In the first half of 2026, NextPlat's total revenues were $21.7 million, down 20% from $27.2 million in the prior year. The decrease was largely driven by a $7.3 million drop in pharmacy prescription revenue, which was partially offset by a $1.7 million increase in pharmacy contract revenue. The company reported a net loss of $1.3 million for the six months ended June 30, 2026, a significant improvement from a loss of $3.7 million in the same period of 2025. This reduction in net loss was attributed to a decrease in operating expenses and an increase in gross profit.

Strategically, NextPlat has been focusing on expanding its healthcare operations, particularly through its pharmacy services. The company has entered into a Membership Interest Purchase Agreement to acquire Scott’s Pharmacy, LLC for $1.5 million, which is expected to enhance its healthcare offerings. Additionally, the company has implemented operational efficiencies and cost reduction measures to improve its financial position. As of June 30, 2026, NextPlat had cash reserves of approximately $11.9 million and $3.8 million available under its At-the-Market (ATM) offering program.

Operationally, NextPlat's e-Commerce segment remained stable, with revenues of $4.1 million for both the second quarter of 2026 and 2025. The company operates multiple e-commerce platforms and has seen consistent engagement metrics. However, the Healthcare Operations segment faced challenges, with a notable decrease in prescription volume and reimbursement rates impacting revenue. Despite these challenges, the gross margin for the healthcare segment improved significantly due to better drug costing and increased volume from new contracted services.

Looking ahead, NextPlat's management is optimistic about its ability to navigate current market conditions and improve its financial performance. The company plans to continue expanding its pharmacy operations and enhancing its e-commerce capabilities. Management believes that the steps taken to improve operational efficiency and the strategic acquisition of Scott’s Pharmacy will position the company for future growth. The outlook remains cautious, with management acknowledging the ongoing challenges in the healthcare reimbursement landscape but expressing confidence in their strategic initiatives to drive revenue and profitability.